Industry influence on occupational and environmental public health

International Journal of Occupational and Environmental Health

Volumn 13, Issue 1, 2007, Pages 107-117

  Huff, James ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Government policy; Industry influence; Science and politics; Science manipulation; Worker health

Indexed keywords

ENVIRONMENTAL HEALTH; GOVERNMENT; HEALTH CARE POLICY; INDUSTRY; OCCUPATIONAL HEALTH; POLITICS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

EID: 33947523021     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2007.13.1.107     Document Type: Review

References (45)

1. Egilman DS, Rankin Bohme S. Over a barrel: corporate corruption of science and its effects on workers and the environment. Int J Occup Environ Health. 2005;11:331-7. 〈www.ijoeh.com〉.
2. LaDou J. Occupational medicine in the United States: a proposal to abolish workers' compensation and reestablish the public health model. Int J Occup Environ Health. 2006;12:154-68.
3. Sass JB, Castleman B, Wallinga D. Vinyl chloride: a case study of data suppression and misrepresentation. Environ Health Perspect. 2005;113:809-12.
4. Richter E, Soskolne CL, LaDou J: Efforts to stop repression bias by protecting whistleblowers. Int J Occup Environ Health. 2001;7:68-71.
5. Kuehn RR. Suppression of environmental science. Am J Law & Med. 2004;30:333-69.
6. Mutetwa B, Chikonyora M, Dozva R, Mazibuko D. Chrysotile fibre levels in asbestos-cement manufacturing in Zimbabwe. African Newsletter on Occupational Health and Safety. 2005;15:66-68. 〈http://www.ttl.fi/ AfricanNewsletter〉 or 〈http://www.ttl.fi/NR/rdonlyres/39784837-0345- 4122-974D-822B6CEC29CA/0/african_newsletter305.pdf〉.
7. Bailar JC 3rd, Ballal SG, Boback M, et al. FIOH-sponsored Newsletter misrepresents asbestos hazards in Zimbabwe. Int J Occup Environ Health. 2006;12:254-8.
8. Wiist WH. Public health and the anticorporate movement: rationale and recommendations. Am J Public Health. 2006; 96:1370-5.
9. Samuels SW. Time to consider real environmental criminal laws? July 31, 2006. Internet message to LaDou J.
10. Teitelbaum D. Internet message to Sheldon Samuels, July 31, 2006.
11. LaDou J. The rise and fall of occupational medicine in the United States. Am J Prev Med. 2002;22:285-95.
12. LaDou J. Occupational medicine: the case for reform. Am J Prev Med. 2005;28:396-402.
13. Sass J. Lockheed Martin and the White House working Together to weaken regulation of chemicals leaching from military superfund sites. Int J Occup Environ Health. 2004;10:330-4.
14. Breilh J, Branco JC, Castleman BI, et al. Texaco and its consultants [letter]. Int J Occup Environ Health. 2005;11:217-20.
15. Egilman DS, Billings MA. Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability. Int J Occup Environ Health. 2005;11:360-71.
16. Egilman DS, Scout. Corporate corruption of science: the case of chromium (VI). Int J Occup Environ Health. 2006;12:169-76..
17. Scout, Egilman D. The case of chromium(VI). Int J Occup Environ Health. 2006;12:426-8.
18. Bailar JC 3rd, Cicolella A, Harrison RJ, et al. IBM, Elsevier Science, and academic freedom. Am J Ind Med. 2007; in press.
19. Melnick RL. Suppression of crucial information in the IARC evaluation of DEHP. Int J Occup Environ Health. 2003;9:84-5; discussion 89.
20. Infante PF, Schuman LD, Dement J, Huff J. Fibrous glass and cancer. Am J Ind Med. 1994;26:559-84.
21. Infante PF, Schuman LD, Huff J. Fibrous glass insulation and cancer: response and rebuttal. Am J Ind Med. 1996;30:113-20.
22. Axelson O, Balbus JM, Cohen G, et al. Re: Regulatory toxicology and pharmacology. Int J Occup Environ Health. 2003;9:386-9; author reply 389-90.
23. Jacobson MF, Sharpe VA, Angell M, et al. Editorial policies on financial disclosure. Nat Neurosci. 2003;6:1001.
24. Ashford NA, Castleman B, Frank AL, et al. The International Commission on Occupational Health (ICOH) and its influence on international organizations. Int J Occup Environ Health. 2002;8:156-62.
25. Richter ED, Berman T. Seattle and the ICOH: the view from the other side of the globe [editorial]. Int J Occup Environ Health. 2000;6:161-3.
26. Watterson A. ICOH and the pesticide industry [editorial]. Int J Occup Environ Health. 2000;6:73-6.
27. LaDou J. The asbestos cancer epidemic. Environ Health Perspect. 2004;112:285-90.
28. Castleman B, Lemen R. The manipulation of international scientific organizations. Int J Occup Environ Health. 1998;4:53-5.
29. Castleman B. Global corporate policies and international "double standards" in occupational and environmental health. Int J Occup Environ Health. 1999;6:61-4.
30. Watterson A. Pesticide health and safety and the work and impact of international agencies: partial successes and major failures. Int J Occup Environ Health. 2001;7:339-47 [the case study is largely drawn from this reference].
31. Sass JB, Colangelo A. European Union bans atrazine, while the United States negotiates continued use. Int J Occup Environ Health. 2006;12:260-7.
32. NIEHS and ACC establish grant program. Environ Health Perspect. 2001;109:12.
33. GAO. NIH and EPA need to improve conflict of interest reviews for research arrangements with private sector entities. U.S. Governmental Accountability Office. GAO-05-191, February 2005.
34. Tomatis L. The IARC monographs program: changing attitudes towards public health. Int J Occup Environ Health. 2002;8:144-52.
35. Huff J. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer. Int J Occup Environ Health. 2002;8:249-70.
36. Melnick RL, Brody C, DiGiangi J, Huff J. The IARC evaluation of DEHP excludes key papers demonstrating carcinogenic effects. Int J Occup Environ Health. 2003;9:400-2.
37. Klaunig JE, Babich MA, Baetcke KP, et al. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol. 2003;33:655-780.
38. Melnick RL, Kamel F, Huff J. Declaring chemicals "not carcinogenic to humans" requires validation, not speculation. Environ Health Perspect. 2003;111:A203-4.
39. Mirer FE. Comment from the union participant in the IARC Working Group that downgraded DEHP. Int J Occup Environ Health. 2003;9:85-7.
40. Needleman H, Huff J. The International Agency for Research on Cancer and obligate transparency. Lancet Oncol. 2005;6:920-1.
41. Abrams H, Anderson H, Anderson J, et al. Business interests influence IPCS/WHO. Arch Environ Health. 1996;51:338-40.
42. Soffritti M, Belpoggi F, Degli Esposti D, Lambertini L, Tibaldi E, Rigano A. First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley rats. Environ Health Perspect. 2006;114:379-85.
43. NTP. Toxicology Studies of Aspartame (CAS No. 22839-47-0) in Genetically Modified (FVB Tg.AC Hemizygous) and B6.129-Cdkn2atm1Rdp (N2) Deficient Mice and Carcinogenicity Studies of Aspartame in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haplo-insufficient] Mice (Feed Studies). GMM-1. National Toxicology Program, Research Triangle Park, NC, October 2005; 1-222.
44. Gordon G. FDA resisted proposals to test aspartame for years. Star Tribune. November 22, 1996. 〈http://www.mindfully. org/Food/Aspartame-FDA- Resisted22nov96.htm〉.
45. UCS. Restoring Scientific Integrity in Policymaking. An Investigation into the Bush Administration's Misuse of Science. Union of Concerned Scientists. 46 pages, 18 Feb 2004. 〈http:// www.ucsusa.org/〉.